Pigmented Lesion and Melanoma Clinic
The Stanford Melanoma Program is structured with parallel melanoma clinics occurring on Wednesday mornings (8 AM to noon) at the Stanford Cancer Center, including the Pigmented Lesion and Melanoma Clinic (staffed by Dr. Susan Swetter [Program Director] and Dr. Jennifer Boldrick), Melanoma Surgery Clinics (staffed by Dr. Ralph Greco and Dr. Mike Yao) and Medical Oncology Clinics (staffed by Dr. Sunil Reddy, Dr. Daniel Chen, and Dr. Joseph Mollick). Additional surgery and medical oncology clinics are available throughout the week.
Through these simultaneously-run melanoma clinics, a Stanford melanoma “tumor board” essentially occurs every week, with frequent communication among specialists to provide a multidisciplinary approach for melanoma patients of all disease stages.
Cutaneous melanoma patients and individuals with clinical atypical nevi (moles) are primarily managed in the Pigmented Lesion and Melanoma Clinic. This clinic was developed to follow patients at increased risk of melanoma based on mole pattern and family history as well as to provide initial evaluation and ongoing surveillance for patients with cutaneous (skin) and more advanced melanoma
Patients with Atypical Mole Syndrome are described as having over 50 to 100 moles with generally 5 or more showing clinical atypia (variation in color or irregular, asymmetric borders, and/or size greater than 8mm diameter). Affected individuals are estimated to have a 5-50-fold increased risk of melanoma depending on family history of melanoma.
The Stanford Pigmented Lesion and Melanoma Clinic employs digital mole mapping to assist in early detection of severely atypical moles and cutaneous melanoma and is a participant in the National Cancer Institute/University of Arizona Phase I/II Cancer Chemoprevention Consortium, designed to prevent melanoma and other skin cancers in high-risk individuals at the outset.
For patient referral, please contact the Stanford Melanoma Program new patient coordinator at (650) 723-5400 (referring physicians) or (650) 498-6000 (new patients).
Trial Administration